
- BioPharm International-06-01-2016
- Volume 29
- Issue 6
Acoustic Separator Streamlines Clarifications
The Cadence Acoustic Separator (CAS) from Pall Life Sciences enables the purification of bioprocesses fluids without the use of primary depth filters or centrifuges.
The Cadence Acoustic Separator (CAS) from Pall Life Sciences enables the purification of bioprocesses fluids without the use of primary depth filters or centrifuges. CAS was developed by FloDesign Sonics and is licensed by Pall. CAS’s acoustic wave separation (AWS) technology applies acoustic forces across a countercurrent flow of bioprocess fluid to generate three-dimensional standing waves that trap cells in their nodes. The cells in the bioprocess fluid will agglomerate and eventually sediment as it loses its buoyancy.
The CAS does not cause any significant increase in temperature or damage to cells or proteins. The CAS system allows for the reduction of 75% of the filtration area and associated buffer volume requirements. AWS technology is applicable for the clarification of biologic products, including recombinant therapeutic proteins and monoclonal antibodies. In addition, the CAS is a single-use clarification system that enables continuous processing.
Articles in this issue
over 9 years ago
Watch Out for the Hangoverover 9 years ago
Scale-Up of Complex Biologicsover 9 years ago
Essentials in Tolerance Design and Setting Specification Limitsover 9 years ago
Make Data Integrity Integral to CGMP Trainingover 9 years ago
Continued Process Verification: State of the Industryover 9 years ago
Scaling Up Progressive Expression Systemsover 9 years ago
Bioprocessing Technology Marches Onover 9 years ago
Controlling Glycosylation for Improved Product Qualityover 9 years ago
Modern Manufacturing Comes of Ageover 9 years ago
Biosimilars: Making the Switch Comes with ChallengesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.